Cargando…

Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases

The monoaminergic systems are the target of several drugs for the treatment of mood, motor and cognitive disorders as well as neurological conditions. In most cases, advances have occurred through serendipity, except for Parkinson's disease where the pathophysiology led almost immediately to th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Giovanni, Giuseppe, Svob Strac, Dubravka, Sole, Montse, Unzeta, Mercedes, Tipton, Keith F., Mück-Šeler, Dorotea, Bolea, Irene, Della Corte, Laura, Nikolac Perkovic, Matea, Pivac, Nela, Smolders, Ilse J., Stasiak, Anna, Fogel, Wieslawa A., De Deurwaerdère, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121249/ https://www.ncbi.nlm.nih.gov/pubmed/27932945 http://dx.doi.org/10.3389/fnins.2016.00541

Ejemplares similares

Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs
por: Svob Strac, Dubravka, et al.
Publicado: (2016)

The GABA(A) receptor α2 subunit gene (GABRA2) is associated with alcohol-related behavior
por: Švob Štrac, Dubravka, et al.
Publicado: (2012)

The involvement of noradrenergic mechanisms in the suppressive effects of diazepam on the hypothalamic-pituitary-adrenal axis activity in female rats
por: Švob Štrac, Dubravka, et al.
Publicado: (2012)

The serotonergic system and cognitive function
por: Švob Štrac, Dubravka, et al.
Publicado: (2016)

HTR1A, HTR1B, HTR2A, HTR2C and HTR6 Gene Polymorphisms and Extrapyramidal Side Effects in Haloperidol-Treated Patients with Schizophrenia
por: Grubor, Mirko, et al.
Publicado: (2020)

Association between reduced brain-derived neurotrophic factor concentration & coronary heart disease
por: Sustar, Aleksandra, et al.
Publicado: (2019)

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
por: Babić, Mirjana, et al.
Publicado: (2014)

Theranostic Biomarkers for Schizophrenia
por: Nikolac Perkovic, Matea, et al.
Publicado: (2017)

The association between HTR1B gene rs13212041 polymorphism and onset of alcohol abuse
por: Svob Strac, Dubravka, et al.
Publicado: (2019)

Epigenetics of Alzheimer’s Disease
por: Nikolac Perkovic, Matea, et al.
Publicado: (2021)

Relationships of Cerebrospinal Fluid Alzheimer’s Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms
por: Babić Leko, Mirjana, et al.
Publicado: (2020)

Short overview on metabolomic approach and redox changes in psychiatric disorders
por: Nedic Erjavec, Gordana, et al.
Publicado: (2017)

SLC6A3, HTR2C and HTR6 Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism
por: Nedic Erjavec, Gordana, et al.
Publicado: (2022)

N-glycomic Profile in Combat Related Post-Traumatic Stress Disorder
por: Tudor, Lucija, et al.
Publicado: (2019)

Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
por: Svob Strac, Dubravka, et al.
Publicado: (2021)

Genetic and Epigenetic Association of Hepatocyte Nuclear Factor-1α with Glycosylation in Post-Traumatic Stress Disorder
por: Tudor, Lucija, et al.
Publicado: (2022)

The Association of the Polymorphisms in the FUT8-Related Locus with the Plasma Glycosylation in Post-Traumatic Stress Disorder
por: Tudor, Lucija, et al.
Publicado: (2023)

Genetic Variants of the Brain-Derived Neurotrophic Factor and Metabolic Indices in Veterans With Posttraumatic Stress Disorder
por: Tudor, Lucija, et al.
Publicado: (2018)

Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia
por: Nikolac Perkovic, Matea, et al.
Publicado: (2020)

Detention in Juvenile Correctional Facilities Is Associated with Higher Platelet Monoamine Oxidase B Activity in Males
por: Podobnik, Josip, et al.
Publicado: (2020)

Reduced Platelet MAO-B Activity Is Associated with Psychotic, Positive, and Depressive Symptoms in PTSD
por: Repovecki, Senka, et al.
Publicado: (2022)

Genotypic and Haplotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Gene Polymorphisms with Particular Clinical Symptoms in Schizophrenia
por: Sagud, Marina, et al.
Publicado: (2023)

Relationship between Brain-Derived Neurotrophic Factor and Cognitive Decline in Patients with Mild Cognitive Impairment and Dementia
por: Nikolac Perkovic, Matea, et al.
Publicado: (2023)

Plasma Brain-Derived Neurotrophic Factor (BDNF) Concentration and BDNF/TrkB Gene Polymorphisms in Croatian Adults with Asthma
por: Sreter, Katherina B., et al.
Publicado: (2020)

Haplotypic and Genotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia
por: Sagud, Marina, et al.
Publicado: (2018)

Moderating Effects of BDNF Genetic Variants and Smoking on Cognition in PTSD Veterans
por: Nedic Erjavec, Gordana, et al.
Publicado: (2021)

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
por: Vuic, Barbara, et al.
Publicado: (2022)

Serotonin Receptor Gene Polymorphisms Are Associated with Cerebrospinal Fluid, Genetic, and Neuropsychological Biomarkers of Alzheimer’s Disease
por: Babić Leko, Mirjana, et al.
Publicado: (2022)

Platelet Serotonin (5-HT) Concentration, Platelet Monoamine Oxidase B (MAO-B) Activity and HTR2A, HTR2C, and MAOB Gene Polymorphisms in Asthma
por: Konjevod, Marcela, et al.
Publicado: (2023)

Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms
por: Vuic, Barbara, et al.
Publicado: (2023)

Association of Lipid Peroxidation Product 4-Hydroxynonenal with Post-Traumatic Stress Disorder †
por: Perković, Matea Nikolac, et al.
Publicado: (2021)

Plasma Brain-Derived Neurotrophic Factor Levels in First-Episode and Recurrent Major Depression and before and after Bright Light Therapy in Treatment-Resistant Depression
por: Kosanovic Rajacic, Biljana, et al.
Publicado: (2023)

New tools for neuroenhancement – what about neuroethics?
por: Erhardt, Julija, et al.
Publicado: (2016)

Difference in Methylation and Expression of Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Mild Cognitive Impairment
por: Kouter, Katarina, et al.
Publicado: (2023)

The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus
por: Bozek, Tomislav, et al.
Publicado: (2017)

Association of MAPT haplotype‐tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: A preliminary study in a Croatian cohort
por: Babić Leko, Mirjana, et al.
Publicado: (2018)

Chronic Administration of Fipronil Heterogeneously Alters the Neurochemistry of Monoaminergic Systems in the Rat Brain
por: Bharatiya, Rahul, et al.
Publicado: (2020)

The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
por: Radosavljevic, Milica, et al.
Publicado: (2023)

Effects of acute and chronic administration of neurosteroid dehydroepiandrosterone sulfate on neuronal excitability in mice
por: Svob Strac, Dubravka, et al.
Publicado: (2016)

Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease
por: Unzeta, Mercedes, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qhca3o9b5luppt7qav8qu6h16h